Strategic recommendations from the STARS project to foster academic drug development
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
The STARS project was funded by Horizon 2020 (grant number 825881). We would like to acknowledge the support that we received from other STARS members while preparing the STARS Common Strategy, including the recommendations.
de Wilde, S., Guchelaar, H.J., Zandvliet, M.L. & Meij., P. Clinical development of gene- and cell-based therapies: overview of the European landscape. Mol. Ther. Methods Clin. Dev. 3, 16073 (2016).
Kinch, M.S., Horn, C., Kraft, Z. & Schwartz, T. Rising academic contributions to drug development: evidence of vigor or trauma? ACS Pharmacol. Transl. Sci. 3, 1427−1429 (2020).
Gilliland, C. T., et al. Putting translational science on to a global stage. Nat. Rev. Drug Discov. 15, 217–218 (2016).
Starokozhko, V. et al. STARS consortium. Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap. Drug Discov. Today 26, 283–288 (2021).
Kallio, M. J. et al. Translating academic drug discovery into clinical development: a survey of the awareness of regulatory support and requirements among stakeholders in Europe. Clin. Pharmacol. Ther. 113, 349–359 (2023).
The authors declare no competing interests.